Buccal insulin may be back in India after Phase III results
This article was originally published in Scrip
Executive Summary
Shreya Life Sciences, the Indian licensee of Generex Biotechnology Corporation, has submitted details of its recently completed Phase III trial of Generex Oral-lyn, the Canadian firm's buccal insulin spray product, to the Indian government seeking approval for marketing and commercialisation.